New York, New York–(Newsfile Corp. – December 30, 2024) – Kuehn Regulation, PLLC, a shareholder litigation regulation agency, is investigating whether or not sure officers and administrators of Akero Therapeutics, Inc. (NASDAQ: NASDAQ:) breached their fiduciary duties to shareholders. The investigation considerations potential self-dealing. Shareholders could also be entitled to damages and company governance reforms. […]